Our goal is to ensure the next generation grows up safe from deadly infectious diseases. We work with partners to develop safe and effective vaccines that protect against preventable diseases and to expand access to these vaccines for people in lower-income countries.
CEO Mark Suzman writes about a virtual summit, which brought together people, organizations, and businesses to raise $8 billion for the COVID-19 response.
Victoria Vrana, a deputy director on the Philanthropic Partnerships team, shares about the launch of PowerOf, a new online platform that connects people eager to make a difference with organizations…
Trevor Mundel provides an update on the COVID-19 Therapeutics Accelerator’s progress in research, manufacturing, and testing. Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of…
Developing and manufacturing a vaccine against COVID-19 is only part of the solution. Coordination, political will, and the infrastructure to support equitable vaccine is distribution will be essential to the…
Dr. Toni Hoover, director of Strategy, Planning, and Management for Global Health at the Gates Foundation, shares what the CoVig Alliance means for the wider fight against COVID-19—and the foundation’s…
Jean Kagubare, deputy director for Health Systems Design, shares the importance of investing in primary health care (PHC) as part of the global response to COVID-19. By strengthening basic health…
On Friday, April 17, Mark Suzman, CEO of the Gates Foundation, joined a conference call with The Optimist subscribers to discuss the foundation’s response to the COVID-19 pandemic. Listen to…
CEO Mark Suzman reflects on the foundation’s unique position to respond to the COVID-19 crisis and shares an update on the foundation’s more than $250 million commitment to funding response…
Oumar Seydi, Africa director for the Bill & Melinda Gates Foundation, shares the foundation’s two-pronged response to coronavirus in Africa: short-term assistance to bolster the immediate response, and long-term support…
Trevor Mundel, who leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries, discusses the first trials funded through the Therapeutics…
